已收盤 11-06 16:00:00 美东时间
-0.210
-2.46%
今日重点评级关注:Citizens:维持Precigen"跑赢大市"评级,目标价从11美元升至12美元;Leerink Partners:维持Arcus Biosciences"跑赢大市"评级,目标价从46美元升至49美元
11-06 16:15
Hillman Solutions shares are trading lower after the company reported mixed Q3 financial results and cut its FY26 sales guidance with its midpoint below estimates.
11-03 05:43
Hillman Solutions Corp. and FC Cincinnati hosted the second annual Trade School Discovery Day at TQL Stadium, offering over 100 students hands-on career exploration in skilled trades. The event aimed to address the region's workforce gap by connecting students with local professionals in construction, roofing, automotive, culinary, and plumbing. Lauren Edwards of Hillman emphasized inspiring the next generation of skilled workers, while Kate Solo...
10-23 11:30
Hillman Solutions Corp. will host a conference call on November 3, 2026, at 8:30 a.m. Eastern Time to discuss its financial results for the thirteen and thirty-nine weeks ended September 26, 2026. The earnings release will be issued after market close on November 2, 2026. President and CEO Jon Michael Adinolfi and CFO Rocky Kraft will present the results. A webcast replay will be available post-presentation.
10-07 11:30
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从49美元升至50美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从24美元升至25美元
10-02 08:33
Canaccord Genuity analyst Brian McNamara maintains Hillman Solutions (NASDAQ:HLMN) with a Buy and lowers the price target from $14 to $13.
10-01 21:44
Hillman Solutions ( ($HLMN) ) just unveiled an announcement. Hillman Solutions ...
09-03 20:18
CINCINNATI, Aug. 19, 2026 – Hillman Solutions Corp. (Nasdaq: HLMN) has published its 2025 Responsibility Report and Fact Sheet, detailing progress in corporate responsibility across people, communities, environment, innovation, and governance. The report highlights employee development, community partnerships, environmental efforts, product innovation, and ethical governance. CEO Jon Michael Adinolfi emphasized Hillman’s commitment to responsible...
08-19 11:30
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
Barclays analyst Matthew Bouley maintains Hillman Solutions (NASDAQ:HLMN) with a Equal-Weight and raises the price target from $10 to $11.
08-10 18:45